skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Toosendanin induces caspase-dependent apoptosis through the p38 MAPK pathway in human gastric cancer cells

Journal Article · · Biochemical and Biophysical Research Communications
; ;  [1];  [2];  [1];  [2];  [1]
  1. Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong (China)
  2. Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong (China)

Highlights: • Toosendanin suppresses viability of various gastric cancer cell lines. • Toosendanin induces G{sub 1}/S cell cycle arrest followed by inhibiting proliferation of AGS and HGC-27 cells. • Toosendanin induces caspase-dependent apoptosis via p38 MAPK signaling pathway in AGS and HGC-27 cells. • Toosendanin can be a promising therapeutic compound for gastric cancer therapy. Although many advances have been made in the treatment of gastric cancer (GC), numerous difficulties, such as the emergence of chemo-drug resistance, continue to lead to disappointing GC prognoses. Thus, novel alternative strategies are urgently needed. The use of natural products could be a viable option to treat GC. Toosendanin (TSN) is a triterpenoid derived from the bark of Melia toosendanin Sieb. et Zucc that has been shown to be highly cytotoxic to multiple cancer cells. As the underlying impact of TSN on GC and its molecular mechanism remain poorly understood, in this study, we performed a series of experiments involving the use of TSN to treat GC cells. In the present study, we showed that TSN suppressed cell viability, inhibited cell proliferation by causing G{sub 1}/S arrest and induced caspase-dependent apoptosis in AGS and HGC-27 cells. The possible mechanism of TSN-induced apoptosis may be associated with the activation of the p38 MAPK pathway. These results demonstrated the potential of TSN as a promising therapeutic compound to treat gastric cancer.

OSTI ID:
23107824
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 505, Issue 1; Other Information: Copyright (c) 2018 Elsevier Inc. All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

TGF{beta}1 induces apoptosis in invasive prostate cancer and bladder cancer cells via Akt-independent, p38 MAPK and JNK/SAPK-mediated activation of caspases
Journal Article · Fri Oct 12 00:00:00 EDT 2012 · Biochemical and Biophysical Research Communications · OSTI ID:23107824

Nur77 inhibits oxLDL induced apoptosis of macrophages via the p38 MAPK signaling pathway
Journal Article · Fri Mar 18 00:00:00 EDT 2016 · Biochemical and Biophysical Research Communications · OSTI ID:23107824

MicroRNA-128 contributes to the progression of gastric carcinoma through GAREM-mediated MAPK signaling activation
Journal Article · Sat Sep 15 00:00:00 EDT 2018 · Biochemical and Biophysical Research Communications · OSTI ID:23107824